Physician

Mark Vining Hendricks, M.D

According to 2025 Medicare claims, Mark Hendricks, M.D (NPI: 1306827639) practices pulmonary disease in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is CENTRAL GEORGIA PULMONARY ASSOCIATES, LLC (NPI: 1669521902; TIN: 582602452) and primary practice location at 31201-2170. Hendricks is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Hendricks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,423 traditional Medicare patients, billed 5,644 HCPCS/CPT codes, and received $314,750 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,945 prescription claims across 692 beneficiaries totaling $3,803,106 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 6,284 claims. Open Payments data shows 72 records totaling $3,899. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,116,919 to $3,803,106. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,653	6,614	$334,330
2016	1,567	6,216	$310,440
2017	1,600	6,725	$346,073
2018	1,704	7,390	$387,739
2019	1,792	6,981	$359,719
2020	1,413	4,495	$217,594
2021	1,407	5,163	$280,993
2022	1,450	4,996	$261,152
2023	1,499	5,159	$310,709
2024	1,423	5,644	$314,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	406	3,351	$1,116,919
2016	417	3,411	$1,582,218
2017	431	3,432	$1,597,445
2018	491	3,400	$1,797,023
2019	562	3,879	$2,120,386
2020	609	4,038	$3,198,341
2021	602	3,800	$3,820,758
2022	609	3,742	$4,037,703
2023	615	3,640	$4,230,867
2024	692	3,945	$3,803,106

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,863	5,774	$526,649
2016	2,219	6,179	$396,785
2017	2,485	6,488	$345,884
2018	2,743	7,512	$345,596
2019	2,704	7,221	$358,306
2020	2,646	7,202	$474,078
2021	2,354	6,765	$540,640
2022	2,143	6,355	$492,873
2023	2,283	6,671	$552,948
2024	2,203	6,284	$451,843

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	495	667	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	792	1,094	$62
94729	Test to examine how well the lungs exchange gases	397	406	$34
71046	X-ray of chest, 2 views	258	290	$21
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	608	777	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	85	2,730	$1,172,119
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	757	28,764	$608,905
Opsumit	Macitentan	28	840	$342,570
Adempas	Riociguat	25	727	$327,553
Nucala	Mepolizumab	64	1,792	$241,222

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	13	123	$121,147
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	63	$47,645
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	78	563	$45,700
A7031	Face mask interface, replacement for full face mask, each	N	144	331	$32,896
A7030	Full face mask used with positive airway pressure device, each	N	145	326	$29,484

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	72	$3,899	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Vining Hendricks, M.D?

Tedicare shows public-source Medicare data for Mark Vining Hendricks, M.D (NPI 1306827639), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Vining Hendricks, M.D have ACO affiliation data?

Mark Vining Hendricks, M.D is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Mark Vining Hendricks, M.D?

Mark Vining Hendricks, M.D is linked to CENTRAL GEORGIA PULMONARY ASSOCIATES, LLC (billing NPI 1669521902) in the available physician profile data.

Does Mark Vining Hendricks, M.D have Open Payments data?

Mark Vining Hendricks, M.D has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.